Medivation, Inc. (MDVN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
81.44+0.02 (+0.02%)
As of 4:00 PM EDT. Market open.
People also watch:
BMRNALXNSGENREGNVRTX
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.00
Prev Close81.42
Bid81.40 x 1000
Ask81.49 x 5200
Day's Range81.43 - 81.48
52wk Range26.41 - 81.48
1y Target EstN/A
Market Cap13.52B
P/E Ratio (ttm)-75.34
Beta1.26
Volume4,050,200
Avg Vol (3m)4,292,837
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Business Wire2 hours ago

    Pfizer Completes Acquisition of Medivation

    Pfizer Inc. today announced the successful completion of its acquisition of Medivation, Inc. . As of the tender offer expiration, 115,574,041 shares of Medivation common stock were validly tendered, representing approximately 69.1% of the shares outstanding and have been accepted for payment under the terms of the tender offer for $81.50 per share in cash, without interest, subject to any required ...

  • Marketwired5 hours ago

    Medivation Highlights New Data From Differentiated Oncology Portfolio at ESMO 2016

    Medivation, Inc. today announced that new data from Company-sponsored and investigator-initiated clinical trials will be presented at the European Society for Medical Oncology 2016 Congress, being held ...

  • Unexpected Twist: Pfizer Scraps Breakup Following Dead Allergen Merger
    Investor's Business Daily2 days ago

    Unexpected Twist: Pfizer Scraps Breakup Following Dead Allergen Merger

    Pfizer ended years of speculation that it would split into separate businesses, one focused on new drugs and the other on off-patent drugs.